Nectar Lifesciences Ltd — Quarterly Results & Earnings

₹9.30

-7.74%

Profit Growth YoY-43.48%Latest quarter

Sales Growth YoY-0.52%Latest quarter

Sales CAGR 5Y-6.77%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-43.48%

🔴 Significant decline

YoY Sales Growth-0.52%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

5.49%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

-4.08

ROE

-11.23%

ROCE

-5.36%

💡

Growth Analysis

Nectar Lifesciences Ltd reported YoY profit growth of -43.48% and revenue growth of -0.52% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -6.77% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Nectar Lifesciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.